Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 28, 2015; 21(8): 2395-2404
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2395
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2395
Table 6 Comparison of baseline characteristics between the surgical treatment group and the non-surgical treatment group n (%)
| Variables | All (n = 119) | Surgical treatment group (n = 17) | Non-surgical treatment group (n = 102) | P value |
| Age (yr) | 52 (30-77) | 52 (30-74) | 51.5 (32-77) | 0.814 |
| Gender, male | 111 (93.3) | 15 (88.2) | 96 (94.1) | 0.320 |
| Etiologies (n) | 0.704 | |||
| HBV/HCV/Alcohol/others | 95/4/7/13 | 12/1/1/3 | 83/3/6/10 | |
| AFP (ng/mL) | 471.2 (0.7-5719.0) | 261.8 (0.7-5719.0) | 603.6 (1.9-5102.0) | 0.879 |
| Maximal tumor size (cm) | 12 (10.0-20.0) | 12(10.0-16.0) | 12 (10.0-20.0) | 0.904 |
| Tumor type | 0.051 | |||
| Well-demarcated | 82 (68.9) | 15 (88.2) | 67 (65.7) | |
| Poorly-demarcated | 37 (31.1) | 2 (11.8) | 35 (34.3) | |
| Location of main tumor | 0.085 | |||
| Left | 18 (15.1) | 5 (29.4) | 13 (12.7) | |
| Right | 101 (84.9) | 12 (70.6) | 89 (87.3) | |
| PVT | 0.094 | |||
| Present | 89 (74.8) | 10 (58.8) | 79 (77.5) | |
| Absent | 30 (25.2) | 7 (41.2) | 23 (22.5) | |
| Stage, modified UICC | 0.071 | |||
| Stage III | 53 (44.5) | 11 (64.7) | 42 (41.2) | |
| Stage IV-A | 66 (55.5) | 6 (35.3) | 60 (58.8) |
- Citation: Song DS, Nam SW, Bae SH, Kim JD, Jang JW, Song MJ, Lee SW, Kim HY, Lee YJ, Chun HJ, You YK, Choi JY, Yoon SK. Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2015; 21(8): 2395-2404
- URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2395.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2395